Sigachi Industries Limited (SIGACHI) Earnings Call Transcripts

9 earnings calls from January 2024 to May 30, 2026

NSEI IN Health Care Pharmaceuticals

Sigachi Industries Limited's Latest Earnings Call - Q4 FY2026

Sigachi Industries Limited reported stable Q4 FY '26 results with total operating income of INR 121.89 crores, an EBITDA of INR 15.4 crores, and a net profit of INR 7.6 crores. The company maintained a focus on operational discipline and strategic expansion, with significant progress in its MCC and CCS projects at Dahej. Management provided strong guidance for FY '27, expecting revenues between INR 650 crores and INR 675 crores, with an EBITDA margin of 18% to 20%, driven by capacity expansions and improved product mix.

Reported metrics

MetricValueContext
Revenue INR 121.89 crores (inline) Q4 FY '26
EBITDA INR 15.4 crores (inline) 12.63% margin
Net Profit INR 7.6 crores (inline) 6.23% PAT margin
MCC Segment Revenue INR 85.33 crores (inline) Q4 FY '26
O&M Segment Revenue INR 14.63 crores (inline) Q4 FY '26
API Segment Revenue INR 17.06 crores (inline) Q4 FY '26

Guidance from management

Sigachi expects FY '27 revenue between INR 650 crores and INR 675 crores, with an EBITDA margin of 18% to 20%, driven by new capacities at Dahej and Jhagadia.

What management said

Yes. Thank you, Darshil. The additional revenues comes from Dahej and Jhagadia, the enhanced capacities. And also API, we are expecting a good growth and also the continued O&M expansion every year, it is giving a good growth. This year, that's why we not -- that is only around 650 to 675 only is the range we expected because the capacities -- expanded capacities of 12,000 metric tonnes from Dahej 2, that is a new fa...
— Subbarami Oruganti, Q4 FY2026 earnings call
Darshil, yes, of course, we will see that. But I would just like to tell you that the first quarter of the next financial year, the ramp-up will not be at absolute 100%. The capacity utilization gradually moves up quarter-on-quarter. So the Q1 will probably be at 30%, Q2 will gradually probably move at 40%, 45% or 50% and likewise, for the last 2 quarters for the new facility?
— Amit Sinha, Q4 FY2026 earnings call

What analysts pressed on

Analysts questioned the timeline for capacity ramp-up and the impact of delayed insurance proceeds on financials. Concerns were raised about the ability to regain customers post-incident and the potential legal repercussions from the Hyderabad plant incident.

Main topics on the call

Read the full Sigachi Industries Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Sigachi Industries Limited

Sigachi Industries Limited (SIGACHI) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NSEI and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 9 calls on record spanning January 19, 2024 to May 30, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 9 Sigachi Industries Limited earnings call transcripts on record, spanning January 19, 2024 to May 30, 2026. Based on this history, Sigachi Industries Limited reports quarterly. The most recent call on file is dated May 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
SIGACHI
Exchange
NSEI
Country
IN
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
9
First call
January 19, 2024
Most recent
May 30, 2026
Reporting cadence
quarterly
Quarter Date
Q4 FY2026 May 30, 2026 Read transcript
Q3 FY2026 Feb 14, 2026 Read transcript
Q2 FY2026 Oct 24, 2025 Read transcript
Q1 FY2026 Jul 25, 2025 Read transcript
Q3 FY2025 Jan 18, 2025 Read transcript
Q2 FY2025 Nov 13, 2024 Read transcript
Q1 FY2025 Aug 6, 2024 Read transcript
Q4 FY2024 May 27, 2024 Read transcript
Q3 FY2024 Jan 19, 2024 Read transcript